Advertisement
Editorial| Volume 354, P14-16, May 01, 2022

Download started.

Ok

Early-onset MINOCA: Prognostic implications and considerations for practice

  • Felice Gragnano
    Correspondence
    Corresponding author at: Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Viale Abramo Lincoln 5, IT- 81100 Caserta, Italy.
    Affiliations
    Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy

    Division of Cardiology, A.O.R.N. “Sant'Anna e San Sebastiano”, Caserta, Italy
    Search for articles by this author
  • Arturo Cesaro
    Affiliations
    Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy

    Division of Cardiology, A.O.R.N. “Sant'Anna e San Sebastiano”, Caserta, Italy
    Search for articles by this author
  • Francesco Pelliccia
    Affiliations
    Department of Cardiovascular Sciences, Sapienza University, Rome, Italy
    Search for articles by this author
  • Giuseppe Limongelli
    Affiliations
    Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, A.O.R.N. Ospedali dei Colli-Monaldi Hospital, Naples, Italy
    Search for articles by this author
      Myocardial infarction with nonobstructive coronary arteries (MINOCA) is common in clinical practice and accounts for about 10% of all patients presenting with myocardial infarction (MI) [
      • Lindahl B.
      • Baron T.
      • Albertucci M.
      • Prati F.
      Myocardial infarction with non-obstructive coronary artery disease.
      ]. The absence of significant coronary stenosis should not be regarded as a benign feature. Patients with MINOCA are at increased risk of recurrent infarction and mortality [
      • Lindahl B.
      • Baron T.
      • Albertucci M.
      • Prati F.
      Myocardial infarction with non-obstructive coronary artery disease.
      ,
      • Pelliccia F.
      • Pasceri V.
      • Niccoli G.
      • et al.
      Predictors of mortality in myocardial infarction and nonobstructed coronary arteries: a systematic review and Meta-regression.
      ] and should not be dismissed as having a ‘false-positive’ diagnosis of MI. Prompt recognition of MINOCA is relevant because secondary prevention strategies can improve patients' prognosis [
      • Lindahl B.
      • Baron T.
      • Albertucci M.
      • Prati F.
      Myocardial infarction with non-obstructive coronary artery disease.
      ,
      • Lindahl B.
      • Baron T.
      • Erlinge D.
      • et al.
      Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease.
      ]. However, this entity remains difficult to clinically distinguish from other nonischemic conditions that manifest with similar symptoms and troponin elevation [
      • Lindahl B.
      • Baron T.
      • Albertucci M.
      • Prati F.
      Myocardial infarction with non-obstructive coronary artery disease.
      ]. Based on the consensus of international societies, a diagnosis of MINOCA should be reserved for patients with MI – according to the fourth universal definition – who also present no stenosis ≥50% in any major epicardial artery on coronary angiography (Table 1) [
      • Agewall S.
      • Beltrame J.F.
      • Reynolds H.R.
      • et al.
      ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.
      ,
      • Tamis-Holland J.E.
      • Jneid H.
      • Reynolds H.R.
      • et al.
      Contemporary diagnosis and Management of Patients with Myocardial Infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association.
      ]. Noteworthy, MINOCA is a working diagnosis and should be confirmed only after carefully excluding nonischemic etiologies of myocardial injury (i.e., myocarditis), inadvertently overlooked coronary obstruction (i.e., occlusion of small/distal vessels), and other possible causes of troponin elevation (i.e., pulmonary embolism). Once these alternatives have been considered and discarded, a diagnosis of MINOCA can be made [
      • Agewall S.
      • Beltrame J.F.
      • Reynolds H.R.
      • et al.
      ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.
      ,
      • Tamis-Holland J.E.
      • Jneid H.
      • Reynolds H.R.
      • et al.
      Contemporary diagnosis and Management of Patients with Myocardial Infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association.
      ]. Early investigation (i.e., within 7–14 days) by cardiac magnetic resonance (CMR) with late gadolinium enhancement is helpful to assess cardiac anatomy and differentiate infarct patterns (i.e., subendocardial/transmural) from nonischemic patterns (i.e., subepicardial/mid-wall). When CMR reveals a myocardial injury that is consistent with an ischemic etiology, a systematic search of the potential causes of MINOCA is necessary to uncover underlying mechanisms [
      • Lindahl B.
      • Baron T.
      • Albertucci M.
      • Prati F.
      Myocardial infarction with non-obstructive coronary artery disease.
      ]. The presence of plaque rupture/erosion is often reported in MINOCA and can be recognized by intravascular imaging (i.e., optical coherence tomography [OCT]). Coronary artery vasospasm may cause persistent ischemia and MINOCA; provocative tests to detect vasomotor abnormalities are safe and informative when adequately performed, although they are used rarely in daily practice [
      • Lindahl B.
      • Baron T.
      • Albertucci M.
      • Prati F.
      Myocardial infarction with non-obstructive coronary artery disease.
      ,
      • Lindahl B.
      • Baron T.
      • Erlinge D.
      • et al.
      Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease.
      ]. Spontaneous coronary artery dissection represents an uncommon cause of MINOCA, except in young females [
      • Lindahl B.
      • Baron T.
      • Albertucci M.
      • Prati F.
      Myocardial infarction with non-obstructive coronary artery disease.
      ]. Coronary microvascular disease is often responsible for MINOCA and could account for about 20% of all cases [
      • Lindahl B.
      • Baron T.
      • Albertucci M.
      • Prati F.
      Myocardial infarction with non-obstructive coronary artery disease.
      ]. Identifying the precise mechanisms of MINOCA remains key to assist clinicians in defining optimal follow-up and treatment strategies in individual patients.
      Table 1Contemporary diagnostic criteria for MINOCA.
      Society (year) Diagnostic Criteria for MINOCA
      American Heart Association (2019) [
      • Tamis-Holland J.E.
      • Jneid H.
      • Reynolds H.R.
      • et al.
      Contemporary diagnosis and Management of Patients with Myocardial Infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association.
      ]
      A diagnosis of MINOCA should be reserved for patients in whom there is an ischemic basis for their clinical presentation. Thus, in the evaluation of patients with a suspected AMI (based on cardiac biomarkers and corroborative clinical evidence), despite the absence of obstructive CAD, it is imperative to exclude:

      • 1)
        clinically overt causes for the elevated troponin (i.e., sepsis, pulmonary embolism);
      • 2)
        clinically overlooked obstructive disease (i.e., complete occlusion of a small coronary artery subsegment resulting from plaque disruption or embolism, or an overlooked ≥50% distal stenosis of a coronary artery);
      • 3)
        clinically subtle nonischemic mechanisms of myocyte injury that can mimic AMI (i.e., myocarditis).
      Once these have been considered and excluded by use of available diagnostic resources, a diagnosis of MINOCA can be made.
      ESC/ACC/AHA/World Heart Federation Task Force (2018) [16] The diagnosis of MINOCA, like the diagnosis of MI, indicates that there is an ischemic mechanism responsible for the myocyte injury (i.e., nonischemic causes such as myocarditis have been excluded). Furthermore, the diagnosis of MINOCA necessitates that obstructive CAD has not been inadvertently overlooked (i.e., spontaneous coronary artery dissection).
      European Society of Cardiology (2016) [
      • Agewall S.
      • Beltrame J.F.
      • Reynolds H.R.
      • et al.
      ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.
      ]
      The diagnosis of MINOCA is made immediately upon coronary angiography in a patient presenting with features consistent with AMI, as detailed by the following criteria:

      • 1)
        AMI criteria
      • a.
        Positive cardiac biomarker (preferably cardiac troponin) defined as a rise and/or fall in serial levels, with at least 1 value above the 99th percentile upper reference limit, AND
      • b.
        Corroborative clinical evidence of infarction evidenced by at least one of the following:
        • i.
          Symptoms of ischemia
        • ii.
          New or presumed new significant ST-T changes or new LBBB
        • iii.
          Development of pathological Q-waves
        • iv.
          Imaging evidence of new loss of viable myocardium or new RWMA
        • v.
          Intracoronary thrombus evident on angiography or at autopsy
      • 2)
        Nonobstructive coronary arteries, defined as the absence of obstructive CAD on angiography, (i.e., no coronary artery stenosis ≥50%), in any potential infarct-related artery.
      • 3)
        No clinically overt specific cause for the acute presentation.
      ACC/AHA: American College of Cardiology/American Heart Association; AMI: acute myocardial infarction; CAD: coronary artery disease; ESC: European Society of Cardiology; LBBB: left bundle branch block; MI: myocardial infarction; MINOCA: myocardial infarction with nonobstructive coronary arteries; RWMA: regional wall motion abnormalities.

      Keywords

      Abbreviations:

      MINOCA (Myocardial infarction with nonobstructive coronary arteries), MI (Myocardial infarction)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lindahl B.
        • Baron T.
        • Albertucci M.
        • Prati F.
        Myocardial infarction with non-obstructive coronary artery disease.
        EuroIntervention. 2021; 17: e875-e887https://doi.org/10.4244/EIJ-D-21-00426
        • Pelliccia F.
        • Pasceri V.
        • Niccoli G.
        • et al.
        Predictors of mortality in myocardial infarction and nonobstructed coronary arteries: a systematic review and Meta-regression.
        Am. J. Med. 2020; 133: 73-83.e4https://doi.org/10.1016/j.amjmed.2019.05.048
        • Lindahl B.
        • Baron T.
        • Erlinge D.
        • et al.
        Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease.
        Circulation. 2017; 135: 1481-1489https://doi.org/10.1161/CIRCULATIONAHA.116.026336
        • Agewall S.
        • Beltrame J.F.
        • Reynolds H.R.
        • et al.
        ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.
        Eur. Heart J. 2017; 38: 143-153https://doi.org/10.1093/eurheartj/ehw149
        • Tamis-Holland J.E.
        • Jneid H.
        • Reynolds H.R.
        • et al.
        Contemporary diagnosis and Management of Patients with Myocardial Infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association.
        Circulation. 2019; 139: e891-e908https://doi.org/10.1161/CIR.0000000000000670
        • Cesaro A.
        • Gragnano F.
        • Calabrò P.
        • et al.
        Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: insights from the START-ANTIPLATELET registry.
        Int. J. Cardiol. 2021; 345: 7-13https://doi.org/10.1016/j.ijcard.2021.10.138
        • Gragnano F.
        • Spirito A.
        • Corpataux N.
        • et al.
        Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition.
        EuroIntervention. 2021; 17: e898-e909https://doi.org/10.4244/EIJ-D-21-00181
        • Cesaro A.
        • Taglialatela V.
        • Gragnano F.
        • et al.
        Low-dose Ticagrelor in patients with high ischemic risk and previous myocardial infarction: a multicenter prospective real-world observational study.
        J. Cardiovasc. Pharmacol. 2020; 76: 173-180https://doi.org/10.1097/FJC.0000000000000856
        • Valgimigli M.
        • Gragnano F.
        • Branca M.
        • et al.
        P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials.
        BMJ. 2021; 373n1332https://doi.org/10.1136/bmj.n1332
        • Magnani G.
        • Bricoli S.
        • Ardissino M.
        • et al.
        Long-term outcomes of early-onset myocardial infarction with non-obstructive coronary artery disease (MINOCA).
        Int. J. Cardiol. 2022; S0167-5273 (00249–2)https://doi.org/10.1016/j.ijcard.2022.02.015

      Linked Article